Onconetix shares are trading higher. Altos Venture reported a 32.5% stake in the company as of September 24 in a 13D filing on Thursday.
Portfolio Pulse from Benzinga Newsdesk
Onconetix shares rose after Altos Venture disclosed a 32.5% stake in the company in a 13D filing.
September 27, 2024 | 12:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Onconetix shares increased following Altos Venture's disclosure of a significant 32.5% stake in the company, as reported in a 13D filing.
The disclosure of a 32.5% stake by Altos Venture in Onconetix is a strong signal of confidence in the company, likely leading to increased investor interest and a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100